Chapters one and two, free, before it prints.
I am Gil Luxenbourg. Twenty-two years a patient, the seventh person licensed for medical cannabis in Israel and the first who did not have to go to court for it. Volume One goes to Amazon this year.
Before it does, I want it read by people who will tell me what is wrong with it. That is what this page is for.
Chapter One is how I got here. Chapter Two is the endocannabinoid system, written the way I wish someone had written it for me. They open on the next page, straight away.
This is the first complete edition of Volume One, shared for feedback before it goes to graphic design and publishing. Text only by design: the layout and the glossary boxes come after the feedback, not before it, so that the words are right first.
1999, an army hospital, three months on a ward, thirty-seven kilos gone. A gastroenterologist who had run out of options handed me five rolled joints. My own doctor asked me why I was trying to destroy his life while he was trying to save mine. What it took to make that legal afterwards: four years, four hundred pages of trial records, six hundred pages of journal.
The endocannabinoid system from the ground up. CB1 and CB2, anandamide and 2-AG, the enzymes that take them apart again, and the reason two people can be handed the same chemovar and report opposite things. This is the chapter most people have never been given, and it is the one that makes everything after it make sense.
If a passage reads badly, if a claim deserves a harder look, if there is a gap where you expected something, I would rather hear it now than read it in a review later.
Put your name down and here is what actually happens:
I am a twenty-two year patient. I founded my country's first patient education programme, taught the first nurses' course in 2008, hold a US patent, and have advised three governments on regulatory framework. I am not a physician. I am the patient who built what the doctors were not building.
Professor Lumir Hanus reviewed the science and helped keep the book true to its sources. Any errors that remain are mine, not his.
Chris Pakalns contributed masterclass material and grounded the book in the realities of the European medical cannabis landscape.
Bjorn Ludvig Kristiansen Persbraten carried the initiative forward and did the editing and proof-reading that turns a draft into a book.
It does not claim that cannabis treats anything. It is not medical advice, and it is not a prescription. It is an education in how the plant and the body meet, so that the conversation you have with your doctor is a better conversation than the one you would otherwise have had.
If you are looking for a book that tells you which strain cures which condition, this is the wrong book, and I would rather you knew that before you gave me your email address.
Chapters one and two open on the next page. No card, no call, no catch.
Open the chaptersThe course that goes with the book
Three videos, about twenty-eight minutes, and no pharmacology at all. It is the method you then use on everything else, mine included: where this subject actually sits, why the strain name on the jar is an expired identity document, and the five evidence tags I grade every claim with, including my own.
It is also where I say out loud that I taught a fixed twenty-eight day tolerance reset from stage for years, went looking for the study behind the number, found that it does not exist, and stopped teaching it. That is the only credential that matters in this field. No card, no call. The rest of the course is paid, and by then you will have seen exactly how I teach.
Watch module one free at wizdomcircles.com
Gil Luxenbourg